-
Reactivity of a monoclonal antibody with human ovarian carcinoma.
A murine monoclonal antibody (OC125) has been developed that reacts with each of six epithelial ovarian carcinoma cell lines and with cryopreserved tumor tissue from 12 of 20 ovarian cancer patients. By contrast, the antibody does not bind to a variety of nonmalignant tissues, including adult and fetal ovary. OC125 reacts with only 1 of 14 cell lines derived from nonovarian neoplasms and has failed to react with cryostat sections from 12 nonovarian carcinomas.
PMID: 7028788 [PubMed - indexed for MEDLINE]
PMCID: PMC370929
-
Cited by 40 PubMed Central articles
-
Significance of postoperative CA-125 decline after cytoreductive surgery in stage IIIC/IV ovarian cancer.
Yoo SC, Yoon JH, Lyu MO, Kim WY, Chang SJ, Chang KH, Ryu HS.
J Gynecol Oncol. 2008 Sep; 19(3):169-72. Epub 2008 Sep 30.
[J Gynecol Oncol. 2008]
-
Use of high density antibody arrays to validate and discover cancer serum biomarkers.
Loch CM, Ramirez AB, Liu Y, Sather CL, Delrow JJ, Scholler N, Garvik BM, Urban ND, McIntosh MW, Lampe PD.
Mol Oncol. 2007 Dec; 1(3):313-20. Epub 2007 Aug 30.
[Mol Oncol. 2007]
-
MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.
Wang Y, Cheon DJ, Lu Z, Cunningham SL, Chen CM, Luo RZ, Xing D, Orsulic S, Bast RC Jr, Behringer RR.
Differentiation. 2008 Dec; 76(10):1081-92. Epub 2008 Jul 2.
[Differentiation. 2008]
- » See all...